BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11602891)

  • 1. Prophylactic total gastrectomy for familial gastric cancer.
    Lewis FR; Mellinger JD; Hayashi A; Lorelli D; Monaghan KG; Carneiro F; Huntsman DG; Jackson CE; Caldas C
    Surgery; 2001 Oct; 130(4):612-7; discussion 617-9. PubMed ID: 11602891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
    Cisco RM; Ford JM; Norton JA
    Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDH1 associated gastric cancer: a report of a family and review of the literature.
    Moran CJ; Joyce M; McAnena OJ
    Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome.
    Newman EA; Mulholland MW
    J Am Coll Surg; 2006 Apr; 202(4):612-7. PubMed ID: 16571431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic total gastrectomy for individuals with germline CDH1 mutation.
    Pandalai PK; Lauwers GY; Chung DC; Patel D; Yoon SS
    Surgery; 2011 Mar; 149(3):347-55. PubMed ID: 20719348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial gastric cancer: overview and guidelines for management.
    Caldas C; Carneiro F; Lynch HT; Yokota J; Wiesner GL; Powell SM; Lewis FR; Huntsman DG; Pharoah PD; Jankowski JA; MacLeod P; Vogelsang H; Keller G; Park KG; Richards FM; Maher ER; Gayther SA; Oliveira C; Grehan N; Wight D; Seruca R; Roviello F; Ponder BA; Jackson CE
    J Med Genet; 1999 Dec; 36(12):873-80. PubMed ID: 10593993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers.
    Lee AF; Rees H; Owen DA; Huntsman DG
    Am J Surg Pathol; 2010 Jul; 34(7):1007-13. PubMed ID: 20534996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer.
    Ghaffari SR; Rafati M; Sabokbar T; Dastan J
    Eur J Surg Oncol; 2010 Jun; 36(6):559-62. PubMed ID: 20471195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary gastric cancer. Genetics and clinical management].
    Medina-Franco H
    Rev Gastroenterol Mex; 2003; 68(1):51-4. PubMed ID: 12940100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment for familial gastric cancer].
    Maehara Y; Baba H; Oda S; Kakeji Y; Emi Y; Sugimachi K
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):523-31. PubMed ID: 11977535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?
    Chun YS; Lindor NM; Smyrk TC; Petersen BT; Burgart LJ; Guilford PJ; Donohue JH
    Cancer; 2001 Jul; 92(1):181-7. PubMed ID: 11443625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary diffuse gastric cancer: diagnosis and management.
    Blair V; Martin I; Shaw D; Winship I; Kerr D; Arnold J; Harawira P; McLeod M; Parry S; Charlton A; Findlay M; Cox B; Humar B; More H; Guilford P
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):262-75. PubMed ID: 16527687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.